The absence of sustained global transmission despite a major regional outbreak of Bundibugyo virus Ebola disease in the Democratic Republic of the Congo and Uganda underpins the market's 96.3% implied probability against a 2026 pandemic. As of mid-August, confirmed cases exceed 4,900 with over 2,300 deaths according to CDC and WHO data, marking the second-largest Ebola epidemic on record, yet the virus remains largely contained to conflict-affected zones in Ituri Province with limited exportations and no evidence of efficient human-to-human spread beyond Africa. Official risk assessments from CDC and WHO classify the likelihood of broader international dissemination as very low due to robust surveillance, contact tracing, and infection-control measures. While a realistic shift could occur if the strain mutates toward higher transmissibility or if regional instability disrupts containment, current epidemiological trends and modeling projections do not support pandemic-level conditions by year-end.